Considering the united platinum/etoposide chemotherapy is the mainstay of treatment for SCLC patients 29, we tested the treatment effect of etoposide/cisplatin plus CILK1-C30 in H446 and H446R cells. Here, CILK1 is linked to small cell lung carcinoma.